COMPASS THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
COMPASS THERAPEUTICS, INC. (CMPX) reported Diluted Shares Outstanding (Weighted Average) of 138.20 million shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-05-05
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 138.20M shares.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 137.70M shares.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 137.60M shares.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 137.40M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2025-03-31 | 138.20M shares 10-Q · filed 2026-05-05 | 137.95M shares derived: average of 2 quarters · filed 2026-05-05 | 137.83M shares derived: average of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | 137.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 137.65M shares derived: average of 2 quarters · filed 2026-03-05 | 137.40M shares 10-K · filed 2026-03-05 | |
| 2024-09-30 | 137.60M shares 10-Q · filed 2025-11-05 | 137.30M shares 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |